Cargando…

Quality by Design-Based Development of Solid Self-Emulsifying Drug Delivery System (SEDDS) as a Potential Carrier for Oral Delivery of Lysozyme

For many years, researchers have been making efforts to find a manufacturing technique, as well as a drug delivery system, that will allow for oral delivery of biopharmaceuticals to their target site of action without impairing their biological activity. Due to the positive in vivo outcomes of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Šahinović, Merima, Hassan, Alharith, Kristó, Katalin, Regdon, Géza, Vranić, Edina, Sovány, Tamás
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058933/
https://www.ncbi.nlm.nih.gov/pubmed/36986855
http://dx.doi.org/10.3390/pharmaceutics15030995
_version_ 1785016754032869376
author Šahinović, Merima
Hassan, Alharith
Kristó, Katalin
Regdon, Géza
Vranić, Edina
Sovány, Tamás
author_facet Šahinović, Merima
Hassan, Alharith
Kristó, Katalin
Regdon, Géza
Vranić, Edina
Sovány, Tamás
author_sort Šahinović, Merima
collection PubMed
description For many years, researchers have been making efforts to find a manufacturing technique, as well as a drug delivery system, that will allow for oral delivery of biopharmaceuticals to their target site of action without impairing their biological activity. Due to the positive in vivo outcomes of this formulation strategy, self-emulsifying drug delivery systems (SEDDSs) have been intensively studied in the last few years as a way of overcoming the different challenges associated with the oral delivery of macromolecules. The purpose of the present study was to examine the possibility of developing solid SEDDSs as potential carriers for the oral delivery of lysozyme (LYS) using the Quality by Design (QbD) concept. LYS was successfully ion paired with anionic surfactant, sodium dodecyl sulphate (SDS), and this complex was incorporated into a previously developed and optimized liquid SEDDS formulation comprising medium-chain triglycerides, polysorbate 80, and PEG 400. The final formulation of a liquid SEDDS carrying the LYS:SDS complex showed satisfactory in vitro characteristics as well as self-emulsifying properties (droplet size: 13.02 nm, PDI: 0.245, and zeta potential: −4.85 mV). The obtained nanoemulsions were robust to dilution in the different media and highly stable after 7 days, with a minor increase in droplet size (13.84 nm) and constant negative zeta potential (−0.49 mV). An optimized liquid SEDDS loaded with the LYS:SDS complex was further solidified into powders by adsorption onto a chosen solid carrier, followed by direct compression into self-emulsifying tablets. Solid SEDDS formulations also exhibited acceptable in vitro characteristics, while LYS preserved its therapeutic activity in all phases of the development process. On the basis of the results gathered, loading the hydrophobic ion pairs of therapeutic proteins and peptides to solid SEDDS may serve as a potential method for delivering biopharmaceuticals orally.
format Online
Article
Text
id pubmed-10058933
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100589332023-03-30 Quality by Design-Based Development of Solid Self-Emulsifying Drug Delivery System (SEDDS) as a Potential Carrier for Oral Delivery of Lysozyme Šahinović, Merima Hassan, Alharith Kristó, Katalin Regdon, Géza Vranić, Edina Sovány, Tamás Pharmaceutics Article For many years, researchers have been making efforts to find a manufacturing technique, as well as a drug delivery system, that will allow for oral delivery of biopharmaceuticals to their target site of action without impairing their biological activity. Due to the positive in vivo outcomes of this formulation strategy, self-emulsifying drug delivery systems (SEDDSs) have been intensively studied in the last few years as a way of overcoming the different challenges associated with the oral delivery of macromolecules. The purpose of the present study was to examine the possibility of developing solid SEDDSs as potential carriers for the oral delivery of lysozyme (LYS) using the Quality by Design (QbD) concept. LYS was successfully ion paired with anionic surfactant, sodium dodecyl sulphate (SDS), and this complex was incorporated into a previously developed and optimized liquid SEDDS formulation comprising medium-chain triglycerides, polysorbate 80, and PEG 400. The final formulation of a liquid SEDDS carrying the LYS:SDS complex showed satisfactory in vitro characteristics as well as self-emulsifying properties (droplet size: 13.02 nm, PDI: 0.245, and zeta potential: −4.85 mV). The obtained nanoemulsions were robust to dilution in the different media and highly stable after 7 days, with a minor increase in droplet size (13.84 nm) and constant negative zeta potential (−0.49 mV). An optimized liquid SEDDS loaded with the LYS:SDS complex was further solidified into powders by adsorption onto a chosen solid carrier, followed by direct compression into self-emulsifying tablets. Solid SEDDS formulations also exhibited acceptable in vitro characteristics, while LYS preserved its therapeutic activity in all phases of the development process. On the basis of the results gathered, loading the hydrophobic ion pairs of therapeutic proteins and peptides to solid SEDDS may serve as a potential method for delivering biopharmaceuticals orally. MDPI 2023-03-20 /pmc/articles/PMC10058933/ /pubmed/36986855 http://dx.doi.org/10.3390/pharmaceutics15030995 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Šahinović, Merima
Hassan, Alharith
Kristó, Katalin
Regdon, Géza
Vranić, Edina
Sovány, Tamás
Quality by Design-Based Development of Solid Self-Emulsifying Drug Delivery System (SEDDS) as a Potential Carrier for Oral Delivery of Lysozyme
title Quality by Design-Based Development of Solid Self-Emulsifying Drug Delivery System (SEDDS) as a Potential Carrier for Oral Delivery of Lysozyme
title_full Quality by Design-Based Development of Solid Self-Emulsifying Drug Delivery System (SEDDS) as a Potential Carrier for Oral Delivery of Lysozyme
title_fullStr Quality by Design-Based Development of Solid Self-Emulsifying Drug Delivery System (SEDDS) as a Potential Carrier for Oral Delivery of Lysozyme
title_full_unstemmed Quality by Design-Based Development of Solid Self-Emulsifying Drug Delivery System (SEDDS) as a Potential Carrier for Oral Delivery of Lysozyme
title_short Quality by Design-Based Development of Solid Self-Emulsifying Drug Delivery System (SEDDS) as a Potential Carrier for Oral Delivery of Lysozyme
title_sort quality by design-based development of solid self-emulsifying drug delivery system (sedds) as a potential carrier for oral delivery of lysozyme
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058933/
https://www.ncbi.nlm.nih.gov/pubmed/36986855
http://dx.doi.org/10.3390/pharmaceutics15030995
work_keys_str_mv AT sahinovicmerima qualitybydesignbaseddevelopmentofsolidselfemulsifyingdrugdeliverysystemseddsasapotentialcarrierfororaldeliveryoflysozyme
AT hassanalharith qualitybydesignbaseddevelopmentofsolidselfemulsifyingdrugdeliverysystemseddsasapotentialcarrierfororaldeliveryoflysozyme
AT kristokatalin qualitybydesignbaseddevelopmentofsolidselfemulsifyingdrugdeliverysystemseddsasapotentialcarrierfororaldeliveryoflysozyme
AT regdongeza qualitybydesignbaseddevelopmentofsolidselfemulsifyingdrugdeliverysystemseddsasapotentialcarrierfororaldeliveryoflysozyme
AT vranicedina qualitybydesignbaseddevelopmentofsolidselfemulsifyingdrugdeliverysystemseddsasapotentialcarrierfororaldeliveryoflysozyme
AT sovanytamas qualitybydesignbaseddevelopmentofsolidselfemulsifyingdrugdeliverysystemseddsasapotentialcarrierfororaldeliveryoflysozyme